EFFECT OF PREOPERATIVE ANTICOAGULANT TREATMENT ON ACTIVATED COAGULATION TIME AND HEPARIN LEVELS DURING NORMOTHERMIC CARDIOPULMONARY BYPASS (CPB)

被引：0
|
作者：
LONGROIS, D
GONCALVES, O
DEPOIX, JP
ENGUERAND, D
PHILIP, Y
MONTRAVERS, P
CHATEL, D
HVASS, U
DESMONTS, JM
机构：
[1] HOP BICHAT,DEPT ANESTHESIA,PARIS,FRANCE
[2] HOP BICHAT,DEPT CARDIOVASC SURG,PARIS,FRANCE
来源：
BRITISH JOURNAL OF ANAESTHESIA | 1995年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
引用
收藏
页码：31 / 31
页数：1
相关论文
共 50 条
  • [21] Measurement of activated clotting time and whole blood heparin concentration during cardiopulmonary bypass
    Takashi Watanabe
    Kazuaki Shirota
    The Japanese Journal of Thoracic and Cardiovascular Surgery, 1998, 46 (6): : 530 - 530
  • [22] LOW ACTIVATED COAGULATION TIME DURING CARDIOPULMONARY BYPASS DOES NOT INCREASE POSTOPERATIVE BLEEDING
    METZ, S
    KEATS, AS
    ANNALS OF THORACIC SURGERY, 1990, 49 (03): : 440 - 444
  • [23] Effect of cardiopulmonary bypass (CPB) time on the degree of platelet dysfunction.
    Greilich, PE
    Kumar, RR
    Douning, LK
    DiMaio, JM
    Augustus, M
    Carr, ME
    BLOOD, 2000, 96 (11) : 65B - 65B
  • [24] CONCENTRATION OF HEPARIN, ACTIVATED COAGULATION TIME AND AT-III DURING CARDIO PULMONARY BYPASS
    TAMURA, H
    MINOJI, T
    ATOBE, M
    MATSUMOTO, M
    KITAMURA, N
    KAWAGOE, H
    ARTIFICIAL ORGANS, 1981, 5 (03) : 333 - 333
  • [25] HEPARIN AND ANTITHROMBIN-III LEVELS DURING CARDIOPULMONARY BYPASS - CORRELATION WITH SUBCLINICAL PLASMA COAGULATION - COMMENTARY
    JOHN, LCH
    DEVERALL, PB
    ANNALS OF THORACIC SURGERY, 1994, 58 (03): : 804 - 805
  • [26] MODIFICATION OF HEMOSTATIC PARAMETERS DURING CARDIOPULMONARY BYPASS (CPB), EFFECT OF APROTININ
    HAUERT, J
    PARISE, P
    CALLEGARI, P
    GARDAZ, JP
    BACHMANN, F
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1029 - 1029
  • [27] Does low-dose aprotinin increase the activated clotting time (ACT) during cardiopulmonary bypass (CPB)
    Haddad, F
    Yazigi, A
    MadiJebara, S
    Hayek, G
    Antakly, MC
    ANESTHESIOLOGY, 1997, 87 (03) : A464 - A464
  • [28] HEPARIN MONITORING DURING CARDIOPULMONARY BYPASS IN MAN - USE OF FLUOROGENIC HEPARIN ASSAY TO VALIDATE ACTIVATED CLOTTING TIME
    HUGHES, DR
    FAUST, RJ
    DIDISHEIM, P
    TINKER, JH
    ANESTHESIA AND ANALGESIA, 1982, 61 (02): : 189 - 190
  • [29] Effect of diabetes on nitric oxide (NO) production during cardiopulmonary bypass (CPB)
    Matata, BM
    Goodall, AH
    Sosnowski, AW
    de Bono, D
    Galinanes, M
    FASEB JOURNAL, 1998, 12 (05): : A799 - A799
  • [30] USE OF ACTIVATED COAGULATION TIME IN INTRAOPERATIVE HEPARIN REVERSAL FOR CARDIOPULMONARY OPERATIONS
    MATTOX, KL
    GUINN, GA
    RUBIO, PA
    BEALL, AC
    ANNALS OF THORACIC SURGERY, 1975, 19 (06): : 634 - 638
12345